| RYVAX | VGENX | RYVAX / VGENX | |
| Total Expense Ratio | 1.63 | 0.45 | 362% |
| Annual Report Gross Expense Ratio | 1.68 | 0.45 | 373% |
| Fund Existence | 28 years | 42 years | - |
| Gain YTD | 47.612 | 21.898 | 217% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 36.8M | 7.31B | 1% |
| Annual Yield % from dividends | 0.44 | 2.68 | 17% |
| Returns for 1 year | 78.05 | 24.33 | 321% |
| Returns for 3 years | 32.29 | 27.18 | 119% |
| Returns for 5 years | 124.55 | 70.02 | 178% |
| Returns for 10 years | -23.66 | 19.16 | -123% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PEGEX | 20.28 | 0.17 | +0.85% |
| PGIM Jennison Mid-Cap Growth R2 | |||
| VAKSX | 10.10 | 0.07 | +0.70% |
| Virtus KAR Small-Mid Cap Growth A | |||
| MKGCX | 36.10 | 0.23 | +0.64% |
| BlackRock Advantage Global K | |||
| CWSAX | 24.03 | 0.15 | +0.63% |
| Carillon Chartwell Small Cap Growth A | |||
| ITHTX | 62.81 | 0.26 | +0.42% |
| Hartford Capital Appreciation R5 | |||